Cargando…

Expression and function of lysophosphatidic acid receptors (LPARs) 1 and 3 in human hepatic cancer progenitor cells

Hepatocellular carcinoma (HCC) is the most common primary cancer of the liver and is characterized by rapid tumor expansion and metastasis. Lysophosphatidic acid (LPA) signaling, via LPA receptors 1–6 (LPARs1–6), regulates diverse cell functions including motility, migration, and proliferation, yet...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zuckerman, Valentina, Sokolov, Eugene, Swet, Jacob H., Ahrens, William A., Showlater, Victor, Iannitti, David A., Mckillop, Iain H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823083/ https://www.ncbi.nlm.nih.gov/pubmed/26701886 http://dx.doi.org/10.18632/oncotarget.6696

Ejemplares similares

Lysophosphatidic Acid Receptor 6 (LPAR6) Is a Potential Biomarker Associated with Lung Adenocarcinoma
por: He, Jian, et al.
Publicado: (2021)

Lysophosphatidic acid mediates the pathogenesis of psoriasis by activating keratinocytes through LPAR5
por: Lei, Li, et al.
Publicado: (2021)

Circular RNA lysophosphatidic acid receptor 3 (circ-LPAR3) enhances the cisplatin resistance of ovarian cancer
por: Liu, Xuemei, et al.
Publicado: (2022)

Platelet-derived lysophosphatidic acid mediated LPAR1 activation as a therapeutic target for osteosarcoma metastasis
por: Takagi, Satoshi, et al.
Publicado: (2021)

HeLa E-Box Binding Protein, HEB, Inhibits Promoter Activity of the Lysophosphatidic Acid Receptor Gene Lpar1 in Neocortical Neuroblast Cells
por: Kim, Nam-Ho, et al.
Publicado: (2019)

Small-Molecule Lysophosphatidic Acid Receptor 5 (LPAR5) Antagonists: Versatile Pharmacological Tools to Regulate Inflammatory Signaling in BV-2 Microglia Cells
por: Plastira, Ioanna, et al.
Publicado: (2019)

A Novel Function of the Lysophosphatidic Acid Receptor 3 (LPAR3) Gene in Zebrafish on Modulating Anxiety, Circadian Rhythm Locomotor Activity, and Short-Term Memory
por: Lin, Yu-Nung, et al.
Publicado: (2020)

Lysophosphatidic Acid Promotes Epithelial–Mesenchymal Transition in Kidney Epithelial Cells via the LPAR1/MAPK-AKT/KLF5 Signaling Pathway in Diabetic Nephropathy
por: Lee, Geon-Ho, et al.
Publicado: (2022)

Lysophosphatidic Acid Receptor 5 (LPAR5) Plays a Significance Role in Papillary Thyroid Cancer via Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin (mTOR) Pathway
por: Wu, Cheng-Yong, et al.
Publicado: (2020)

Alpha conotoxin-BuIA globular isomer is a competitive antagonist for oleoyl-L-alpha-lysophosphatidic acid binding to LPAR6; A molecular dynamics study
por: Younis, Saima, et al.
Publicado: (2017)

Lysophosphatidic Acid Mediates Imiquimod-Induced Psoriasis-like Symptoms by Promoting Keratinocyte Proliferation through LPAR1/ROCK2/PI3K/AKT Signaling Pathway
por: Kim, Donghee, et al.
Publicado: (2021)

Designing Dual Inhibitors of Autotaxin-LPAR GPCR Axis
por: Banerjee, Souvik, et al.
Publicado: (2022)

An LPAR(5)-antagonist that reduces nociception and increases pruriception
por: Langedijk, Jacqueline, et al.
Publicado: (2022)

microRNA-329 reduces bone cancer pain through the LPAR1-dependent LPAR1/ERK signal transduction pathway in mice
por: Wu, Xian-Ping, et al.
Publicado: (2019)

Elevated plasma levels of lysophosphatidic acid and aberrant expression of lysophosphatidic acid receptors in adenomyosis
por: Yang, Bicheng, et al.
Publicado: (2017)

The Roles of Lpar1 in Central Nervous System Disorders and Diseases
por: Xiao, Dongqiong, et al.
Publicado: (2021)

Generation of an Lpar1-EGFP Fusion Knock-in Transgenic Mouse Line
por: Rivera, Richard, et al.
Publicado: (2021)

2-Carba-lysophosphatidic acid is a novel β-lysophosphatidic acid analogue with high potential for lysophosphatidic acid receptor activation and autotaxin inhibition
por: Fukasawa, Keiko, et al.
Publicado: (2021)

Reduction of LPAR1 Expression in Neuroblastoma Promotes Tumor Cell Migration
por: Liu, Xiangjun, et al.
Publicado: (2022)

Infiltration of LPAR5(+) macrophages in osteosarcoma tumor microenvironment predicts better outcomes
por: He, Yi, et al.
Publicado: (2022)

Inhibition of LPA-LPAR1 and VEGF-VEGFR2 Signaling in IPF Treatment
por: Luo, Ya-Li, et al.
Publicado: (2023)

Effect of lysophosphatidic acid on the follicular development and the expression of lysophosphatidic acid receptor genes during in vitro culture of mouse ovary
por: Abedpour, Neda, et al.
Publicado: (2018)

Pharmacological activation of lysophosphatidic acid receptors regulates erythropoiesis
por: Lin, Kuan-Hung, et al.
Publicado: (2016)

Prevention of age-associated neuronal hyperexcitability with improved learning and attention upon knockout or antagonism of LPAR2
por: Fischer, Caroline, et al.
Publicado: (2020)

Lysophosphatidic acid-3 receptor-mediated feed-forward production of lysophosphatidic acid: an initiator of nerve injury-induced neuropathic pain
por: Ma, Lin, et al.
Publicado: (2009)

Activation of fibroblast-like synoviocytes derived from rheumatoid arthritis via lysophosphatidic acid–lysophosphatidic acid receptor 1 cascade
por: Miyabe, Yoshishige, et al.
Publicado: (2014)

The autotaxin-lysophosphatidic acid–lysophosphatidic acid receptor cascade: proposal of a novel potential therapeutic target for treating glioblastoma multiforme
por: Tabuchi, Sadaharu
Publicado: (2015)

Role of LPAR3, PKC and EGFR in LPA-induced cell migration in oral squamous carcinoma cells
por: Brusevold, Ingvild J, et al.
Publicado: (2014)

In vivo collective cell migration requires an LPAR2-dependent increase in tissue fluidity
por: Kuriyama, Sei, et al.
Publicado: (2014)

Conditional Lpar1 gene targeting identifies cell types mediating neuropathic pain
por: Rivera, Richard R., et al.
Publicado: (2020)

LPAR1, Correlated With Immune Infiltrates, Is a Potential Prognostic Biomarker in Prostate Cancer
por: Shi, Jingqi, et al.
Publicado: (2020)

Lysophosphatidic Acid and Glutamatergic Transmission
por: Roza, Carolina, et al.
Publicado: (2019)

LSD1 controls metastasis of androgen-independent prostate cancer cells through PXN and LPAR6
por: Ketscher, A, et al.
Publicado: (2014)

Expression of lysophosphatidic acid receptors in the human lower esophageal sphincter
por: FENG, YONG, et al.
Publicado: (2014)

Abrogation of lysophosphatidic acid receptor 1 ameliorates murine vasculitis
por: Miyabe, Chie, et al.
Publicado: (2019)

Lysophosphatidic Acid Receptors: Biochemical and Clinical Implications in Different Diseases
por: Xiang, Hongjiao, et al.
Publicado: (2020)

Control of Intestinal Epithelial Permeability by Lysophosphatidic Acid Receptor 5
por: Wang, Mo, et al.
Publicado: (2021)

Lysophosphatidic Acid Analogue rather than Lysophosphatidic Acid Promoted the Bone Formation In Vivo
por: Yu, Zi-Li, et al.
Publicado: (2018)

Altered cleavage plane orientation with increased genomic aneuploidy produced by receptor-mediated lysophosphatidic acid (LPA) signaling in mouse cerebral cortical neural progenitor cells
por: McDonald, Whitney S., et al.
Publicado: (2020)

Inhibition of lysophosphatidic acid receptors 1 and 3 attenuates atherosclerosis development in LDL-receptor deficient mice
por: Kritikou, Eva, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_hskjcmn6oqhhd6pmr01cfs2psp